Between Patents and Patients: Humira Case Study
Humira's wide range of indications has earned it the nickname "Swiss army knife" of pharmaceuticals. The success of Humira can be attributed not only to its therapeutic benefits but also to its patent and pricing practices. Over the past two decades, AbbVie has increased the drug's price 30 times.